Diagnosis and management of a severe ALK-positive pneumonia-type lung adenocarcinoma: a case report

20260 citationsJournal Articlegold Open Access

Authors

Ting Su · Kunming University of Science and Technology

Qibo Zhang · Kunming University of Science and Technology

Mengyun Wang · Nanjing University of Science and Technology

Qifan Jing · Nanjing University of Science and Technology

Jiani C. Yin · Nanjing University of Science and Technology

Kai Wang · Kunming University of Science and Technology

Jian He

Abstract

This case highlights the importance of genetic profiling and rapid and substantial efficacy of alectinib in treating ALK-positive PLADC, reinforcing the role of ALK inhibitors in managing severe cases and offering valuable insights for clinical strategies.

Topics & Keywords

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Discover Oncology

DOI: 10.1007/s12672-026-04890-9

Field-Weighted Citation Impact: 0.00